Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

74.39 +0.92 (+1.25%)
Streaming Delayed Price Updated: 3:16 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
News headline image
Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified Stocks
Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season. 
Via StockStory
News headline image
Price Over Earnings Overview: Boston Scientific ↗
 
Via Benzinga
News headline image
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Wednesday. Stay informed about the latest market trends. 
Via Chartmill
News headline image
Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock ↗
 
Via Benzinga
News headline image
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Beyond The Numbers: 17 Analysts Discuss Boston Scientific Stock ↗
 
Via Benzinga
News headline image
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
$100 Invested In Boston Scientific 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Is BOSTON SCIENTIFIC CORP (NYSE:BSX) suited for high growth investing? ↗
A fundamental and technical analysis of (NYSE:BSX): BOSTON SCIENTIFIC CORP (NYSE:BSX) may be suited for high growth investing, we'll explore why in this article. 
Via Chartmill
News headline image
Would Mark Minervini consider BOSTON SCIENTIFIC CORP (NYSE:BSX) a top stock pick? ↗
A fundamental and technical analysis of (NYSE:BSX): Why BOSTON SCIENTIFIC CORP (NYSE:BSX) is Poised for High Growth. 
Via Chartmill
News headline image
Q4 Earnings Roundup: CooperCompanies (NASDAQ:COO) And The Rest Of The Medical Devices & Supplies - Diversified Segment
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including CooperCompanies (NASDAQ:COO) and its peers. 
Via StockStory
News headline image
Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes ↗
Goldman Sachs upgrades GE Healthcare to Buy, raising its price target to $100, as analysts see market stabilization and China sales recovering faster than expected. 
Via Benzinga
News headline image
What Does the Market Think About Boston Scientific? ↗
 
Via Benzinga
News headline image
2 Reasons to Like BSX (and 1 Not So Much)
Since March 2020, the S&P 500 has delivered a total return of 97.5%. But one standout stock has nearly doubled the market - over the past five years, Boston Scientific has surged 176% to $97 per share.... 
Via StockStory
Topics Stocks
News headline image
ResMed Among Top Stocks For Recent And Long-Term Profit Growth ↗
A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue? 
Via Investor's Business Daily
News headline image
What To Expect From CooperCompanies’s (COO) Q4 Earnings
Medical device company CooperCompanies (NASDAQ:COO) will be reporting results tomorrow after market close. Here’s what you need to know. 
Via StockStory
News headline image
Why the high growth investor may take a look at BOSTON SCIENTIFIC CORP (NYSE:BSX). ↗
Should you consider BOSTON SCIENTIFIC CORP (NYSE:BSX) for high growth investing? A fundamental and technical analysis of (NYSE:BSX). 
Via Chartmill
News headline image
Boston Scientific To Acquire SoniVie For $400 Million, Expanding Hypertension Treatment Portfolio ↗
Boston Scientific will acquire SoniVie for up to $600 million on 100% basis, adding the TIVUS ultrasound system to its hypertension treatment pipeline. Deal closes in H1 2025. 
Via Benzinga
News headline image
1 Growth Stock with All-Star Potential and 2 to Brush Off
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s... 
Via StockStory
News headline image
Top Stock Reports For Goldman Sachs, Progressive & Boston Scientific ↗
Today's Research Daily features new research reports on 16 major stocks, including The Goldman Sachs Group, Inc., The Progressive Corp. and Boston Scientific Corp., as well as micro-cap stock... 
Via Talk Markets
Topics Stocks / Equities
News headline image
Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at medical devices & supplies - diversified... 
Via StockStory
News headline image
Which S&P500 stocks are moving on Tuesday? ↗
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday. 
Via Chartmill
News headline image
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - diversified stocks fared in Q4,... 
Via StockStory
News headline image
Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Neogen (NASDAQ:NEOG) and its peers. 
Via StockStory
News headline image
UroGen Pharma Ltd. (NASDAQ: URGN), CS Diagnostics Corp. (OTCQB: CSDX) and Boston Scientific (NYSE: BSX) Advancing Cancer Treatment Technology – More Stocks Inside
Via AB Newswire
News headline image
Baxter Earnings: What To Look For From BAX
Healthcare company Baxter International (NYSE:BAX) will be reporting earnings tomorrow morning. Here’s what investors should know. 
Via StockStory
News headline image
What To Expect From Baxter’s (BAX) Q4 Earnings
Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results tomorrow morning. Here’s what investors should know. 
Via StockStory
News headline image
ResMed Getting Close To Elite Stock Group Entry ↗
ResMed also boasts a 93 Composite Rating. The best growth stocks often have a 90 or higher Composite as they begin their biggest runs. 
Via Investor's Business Daily
News headline image
Q4 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Boston Scientific (NYSE:BSX)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Boston Scientific (NYSE:BSX) and the best... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.